As of December 31, 2025, the Company operates through several reporting segments: Technology and consulting services conducted by Transuite.Org Inc.; online medical education services conducted by Solan (Shenzhen) Technology Co., Ltd., acquired on September 29, 2025; and intelligent infrastructure and e-bike charging management solutions conducted by Goldfinch-Chong (Fuzhou) Technology Co., Ltd., acquired on December 31, 2025. The primary operating activities for the year ended December 31, 2025, included strategic consulting and technology-related services such as business solution development and digital platform deliverables. The online medical education segment began operations following the acquisition of Solan (Shenzhen) Technology Co., Ltd. The intelligent infrastructure segment related to Goldfinch-Chong (Fuzhou) Technology Co., Ltd. was acquired at year-end and did not significantly impact operating results for 2025. The chief operating decision maker evaluates segment performance based on operating results, including revenue and net income or loss. Segment assets are reported in the Consolidated Balance Sheets. The Company's segments by entity and operations include Transuite (Technology & Consulting), Solan (Shenzhen) (Online Medical Education), Xirangsheng (Online Health Technology), Goldfinch HK (Charging Infrastructure), Goldfinch-Chong (E-bike Charging), SolanAI Global (Web 3 Infrastructure), Jiansheng & Yuan Qi (AI Software Development), and Goldfinch BVI & Crestar HK (Corporate/Holding). For the year ended December 31, 2025, the Company reported revenue of $115,000, primarily from strategic consulting and technology service engagements.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.